Category: Cannabis Stocks
DEA Rescheduling Hearing Puts Cannabis Stocks in Focus Ahead of a July 15 Deadline
The DEA’s cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.
Innovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating Thesis
Innovative Industrial’s AFFO was stable at $1.88/share, and leverage is still low for a REIT. Click here to read why…
3 reasons to buy Green Thumb Industries stock hand over fist
Green Thumb continues to execute while competitors struggle.
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
This vertically integrated cannabis operator reported significant insider selling in its latest SEC disclosure.
Calif. pot company skyrockets to $1B valuation following Trump action
This year has been a roller coaster for the massive California cannabis grower.
CRON strengthens global footprint: Is the cannabis stock worth buying?
Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and executes on several…
Trulieve’s NYSE listing is historic. But is the stock still worth buying?
The listing matters, but fundamentals matter more.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are…
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more…
The 5-minute investor podcast, ep. 65: Cannabis stocks cultivating alpha
Welcome to episode 65 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver…
Recent Comments